Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
11/2004
11/02/2004US6812229 Carbamate derivative and agricultural/horticultural fungicide
11/02/2004CA2153903C Process for the preparation of 10-desacetoxybaccatin iii
11/02/2004CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
10/2004
10/28/2004WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004WO2004092113A1 Optically active 2-allylcarboxylic acid derivative and process for producing the same
10/28/2004WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same
10/28/2004US20040214846 A heteroaryl carbamic acid, secondary amide or amine, or phthalimidoyl derivatives; prevent from getting the disease or condition; cognitive impairment, Down's syndrome, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type, cerebral amyloid angiopathy, neurodegenerative disease
10/28/2004US20040214801 9-Substituted minocycline compounds
10/28/2004US20040214328 Multifunctional molecular complexes for gene transfer to cells
10/28/2004CA2521915A1 Alpha substituted carboxylic acid as ppar modulators
10/27/2004EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor
10/27/2004EP1471053A2 Process using a cyclic carbonate reactant and beta-hydroxyurethanes thereby obtained
10/27/2004EP1470201A1 Waterborne coating compositions containing materials dispersed with water-soluble carbamate materials
10/27/2004EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/27/2004CN1541096A Compounds which mimic chemical and biological properties of discodermolide
10/27/2004CN1172911C Phtalimido arylpiperazines as alpha IA receptor antagonists useful in the treatment of benign prostatic hyperplasia
10/26/2004US6809215 Method for hydrogenation of aromatic urethanes in the presence of a supported ruthenium catalyst
10/26/2004US6809207 Amino acid derivatives
10/26/2004US6809190 Method comprising introducing one type or two or more types of a functional molecule post-synthetically following introduction of a precursor monomer unit into a peptide nucleic acid oligomer
10/26/2004US6809093 Drug resistance therapy
10/21/2004WO2004089934A1 Processes for the preparation of n-((((pyridinyloxy) -phenylamino) quinazolinyl)- allyl) acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates
10/21/2004WO2004089885A1 Novel compounds
10/21/2004WO2004089880A2 Carbamates useful as fragances
10/21/2004US20040210089 Reacting n-protected-3-oxazolidin-5-one derivative with halomethyl lithium; decyclizing and reducing; economic, efficient, industrial scale
10/21/2004US20040210059 Carboxylic acids, optionally in the form of amino acids, react with chloroformates to yield intermediates, which react with amines
10/21/2004US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004US20040209949 Resorcinol derivatives
10/21/2004US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide
10/21/2004CA2521348A1 Processes for the preparation of n-((((pyridinyloxy)-phenylamino) quinazolinyl)-allyl) acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates
10/20/2004EP1468680A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
10/20/2004EP1056720B1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
10/20/2004CN1538964A Substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
10/20/2004CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides
10/19/2004US6806384 Production method of β-amino-α-hydroxycarboxylic acid
10/19/2004US6806365 N-alkanoylphenylalamine derivatives
10/14/2004US20040204494 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/13/2004EP1465863A1 Potassium channel modulators
10/13/2004EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
10/13/2004EP1465858A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
10/13/2004EP1465615A1 Tricyclic-bis-enone derivatives and methods of use thereof
10/13/2004CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy
10/12/2004US6803480 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/12/2004US6803383 Utilizing selective inhibitors of the binding of integrin alpha v beta 3 with matrix metalloproteinase 2
10/12/2004US6803381 Carbamic acid derivatives
10/07/2004WO2004085344A2 Production of oxy-michael adducts
10/07/2004US20040199024 Hydroformylation
10/07/2004US20040199013 Method for obtaining an ammonium carbamate solution from a gas mixture containing nh3, h2o and co2
10/07/2004US20040198977 novel sunscreen agents such as Dipotassium Salt of 2-(4-acetamidobenzylidene)malonic Acid or Dipiperidinium Salt of 2-(4-aminobenzylidene)malonic Acid; absorbing within the region of UV-B radiation; cosmetics; photostability, water solubility
10/07/2004US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
10/07/2004US20040198716 Cysteine protease inhimbitors
10/07/2004DE10313319A1 Verfahren zur Hydroformylierung A process for the hydroformylation
10/06/2004EP1464638A1 Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
10/06/2004EP1463783A1 Water-soluble carbamate materials
10/06/2004EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof
10/06/2004EP1463713A1 Prodrugs of excitatory amino acids
10/06/2004EP1101755B1 Anthranilic acid derivatives
10/06/2004EP0975560A4 Chiral separations of amino acids
10/06/2004CN1169785C Method for synthesizing anilino-formate by using non-phosgene path
10/05/2004US6800766 Catalyzing the decyclization of racemic and diastereomeric epoxides mixtures in the presence of a non-racemic, chiral catalyst; pharmaceutical synthesis
09/2004
09/30/2004WO2004083258A2 Branched water-soluble polymers and their conjugates
09/30/2004WO2004082677A1 Substituted p-diaminobenzene derivatives
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004US20040192779 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
09/30/2004DE10312625A1 Method for preparing functional peptide nucleic acids, useful e.g. in gene therapy and as detection probes, using protected synthon that allows subsequent reaction with functional carboxylic acid
09/30/2004CA2519582A1 Substituted p-diaminobenzene derivatives
09/30/2004CA2519092A1 Branched water-soluble polymers and their conjugates
09/29/2004EP1461320A2 Enantioselective transformation of alfa,beta-unsaturated ketones using chiral organic catalysts
09/29/2004EP1461309A1 Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates
09/29/2004EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity
09/29/2004EP1202959B1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha
09/29/2004EP1100483B1 Glucocorticoid-selective anti-inflammatory agents
09/29/2004EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
09/29/2004CN1533400A Probes, system and methods for drug discovery
09/29/2004CN1533362A Method for obtaining ammonium carbamate solution from gas mixture containing NH3, H2O and CO2
09/29/2004CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity
09/29/2004CN1532191A Process for producing Ne-teriary butoxy carbonyl lysine
09/29/2004CN1532190A Method for producing N-benzyloxy carbonyl glutamic acid
09/29/2004CN1168705C Diquaternary-base diphenyl surface reactive agent and its preparation process
09/28/2004US6797731 Resorcinol derivatives
09/28/2004US6797730 Peptide deformylase inhibitors
09/28/2004US6797522 Solid phase synthesis; libraries; enzyme inhibitors; chromatography
09/23/2004WO2004080492A1 Methods of radiofluorination of biologically active vectors
09/23/2004US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents
09/23/2004US20040186287 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides
09/23/2004US20040186061 Novel derivatives of 3,3-diphenylpropylamines
09/23/2004CA2518889A1 Methods of radiofluorination of biologically active vectors
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004CN1167670C Aryl carboxylic acid and tetrazole derivant
09/22/2004CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha
09/21/2004US6794392 Cell differentiation inducer
09/16/2004WO2004050231A3 (bio) organic oligomers for the preparation of macromolecules
09/16/2004US20040181094 Reaction of alkyne and nucleophile in the presence of Ruthenium oxo catalysts with displacement for synthesis of propargylamine or propargyl ethers
09/16/2004US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/16/2004US20040180939 Acetyl 2-hydroxy-1, 3-diaminoalkanes
09/16/2004US20040180930 excellent suppressing effect to cell injury caused by radicals and neurotoxicity induced by excitatory nuerotransmitters such as glutamate
09/15/2004EP1456171A1 Substituted cyclohexane derivatives
09/15/2004EP1456165A1 Induction of apoptosis in cancer cells
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 157